Table 4.
Clinical outcome according to CMR study referral indication
| All patients | CMR indication | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| VT (n = 114) | CM (n = 53) | Viability (n = 9) | Other (n = 2) | |||||||
| LGE (+) | LGE (−) | LGE (+) | LGE (−) | LGE (+) | LGE (−) | LGE (+) | LGE (−) | |||
| (n = 44) | (n = 7) | (n = 19) | (n = 0) | (n = 5) | (n = 0) | (n = 1) | (n = 1) | |||
| Outcome | Death | 30 | 13 | 2 | 10 | 0 | 4 | 0 | 0 | 1 |
| OHT | 7 | 3 | 1 | 2 | 0 | 1 | 0 | 0 | 0 | |
| LVAD | 8 | 3 | 0 | 4 | 0 | 0 | 0 | 1 | 0 | |
| Recurrent VT | 31 | 25 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | |
| CABG | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |
CM, cardiomyopathy; LVAD, left ventricular assist device; OHT, orthotopic heart transplantations.